Total Funding
4
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3131293
Isconova is a research and development firm that develops and commercializes adjuvants and vaccines.
About the Company
Isconova AB is an R&D company that develops and commercializes adjuvants and vaccines. It provides adjuvants for veterinary and human vaccines for an enhanced immune reaction with a longer duration. The products of the company include Matrix-M, which is a cell-mediated and antibody-mediated immune response for use in vaccines for humans, dogs,
and cats. Matrix-C vaccines are used for horses, and Matrix-Q vaccines are used for cows and fish. Matrix-F is also used for fish. It also offers AbISCO research reagents, including AbISCO-100, for use in saponin-sensitive animal species, such as mice.
